Affimed (NASDAQ:AFMD – Get Rating) and AbCellera Biologics (NASDAQ:ABCL – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations and valuation. Volatility & Risk Affimed has a beta of 2.51, indicating that […]